Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Mazereeuw

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Neuroinflammation|July 6, 2014
Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating studyGraham Mazereeuw, Nathan Herrmann, Hongbin Xu, et al.
Neuroscience and Biobehavioral Reviews|June 27, 2013
Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegenerationGraham Mazereeuw, Nathan Herrmann, Steffany A L Bennett, et al.
Cardiovascular Psychiatry and Neurology|December 13, 2017
Baseline Oxidative Stress Is Associated with Memory Changes in Omega-3 Fatty Acid Treated Coronary Artery Disease PatientsGraham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
Neuroscience and Biobehavioral Reviews|April 10, 2013
Potential roles of zinc in the pathophysiology and treatment of major depressive disorderWalter Swardfager, Nathan Herrmann, Roger S McIntyre, et al.
Brain, Behavior, and Immunity|October 16, 2016
Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patientsGraham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
Journal of Clinical Psychopharmacology|August 17, 2016
Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled TrialGraham Mazereeuw, Nathan Herrmann, Paul I Oh, et al.
Neuropsychiatric Disease and Treatment|September 18, 2015
Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating studyGraham Mazereeuw, Nathan Herrmann, Hongbin Xu, et al.
Drug Safety|April 25, 2020
Oxycodone, Hydromorphone, and the Risk of Suicide: A Retrospective Population-Based Case-Control StudyGraham Mazereeuw, Tara Gomes, Erin M Macdonald, et al.
Psychosomatic Medicine|November 2, 2018
Association Between Endothelial Function and Cognitive Performance in Patients With Coronary Artery Disease During Cardiac RehabilitationMahwesh Saleem, Nathan Herrmann, Adam Dinoff, et al.
Journal of the American Heart Association|May 7, 2018
Novel Phospholipid Signature of Depressive Symptoms in Patients With Coronary Artery DiseaseParco Chan, Ivonne Suridjan, Dana Mohammad, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Neuroinflammation|July 6, 2014
Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating studyGraham Mazereeuw, Nathan Herrmann, Hongbin Xu, et al.
Neuroscience and Biobehavioral Reviews|June 27, 2013
Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegenerationGraham Mazereeuw, Nathan Herrmann, Steffany A L Bennett, et al.
Cardiovascular Psychiatry and Neurology|December 13, 2017
Baseline Oxidative Stress Is Associated with Memory Changes in Omega-3 Fatty Acid Treated Coronary Artery Disease PatientsGraham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
Neuroscience and Biobehavioral Reviews|April 10, 2013
Potential roles of zinc in the pathophysiology and treatment of major depressive disorderWalter Swardfager, Nathan Herrmann, Roger S McIntyre, et al.
Brain, Behavior, and Immunity|October 16, 2016
Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patientsGraham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
Journal of Clinical Psychopharmacology|August 17, 2016
Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled TrialGraham Mazereeuw, Nathan Herrmann, Paul I Oh, et al.
Neuropsychiatric Disease and Treatment|September 18, 2015
Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating studyGraham Mazereeuw, Nathan Herrmann, Hongbin Xu, et al.
Drug Safety|April 25, 2020
Oxycodone, Hydromorphone, and the Risk of Suicide: A Retrospective Population-Based Case-Control StudyGraham Mazereeuw, Tara Gomes, Erin M Macdonald, et al.
Psychosomatic Medicine|November 2, 2018
Association Between Endothelial Function and Cognitive Performance in Patients With Coronary Artery Disease During Cardiac RehabilitationMahwesh Saleem, Nathan Herrmann, Adam Dinoff, et al.
Journal of the American Heart Association|May 7, 2018
Novel Phospholipid Signature of Depressive Symptoms in Patients With Coronary Artery DiseaseParco Chan, Ivonne Suridjan, Dana Mohammad, et al.
Pageof 2